Immunogenic Lncs to cancer therapy
- PMID: 36881653
- DOI: 10.1126/scisignal.adh4085
Immunogenic Lncs to cancer therapy
Abstract
LncRNA-derived peptides enhance T lymphocyte responses to tumors in mice.
Comment on
-
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response.Nat Commun. 2023 Feb 25;14(1):1078. doi: 10.1038/s41467-023-36826-0. Nat Commun. 2023. PMID: 36841868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
